- Filed
- Feb 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Feb 10, 2025 | 40.67M sh |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $6.99M |
| Cash And Equivalents | Q3 2025 · Mar 31, 2024 | $9.23M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $1.38M |
| Current Liabilities | Q3 2025 · Mar 31, 2024 | $1.46M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $1.89M |
| Total Liabilities | Q3 2025 · Mar 31, 2024 | $2.27M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $7.33M |
| Current Assets | Q3 2025 · Mar 31, 2024 | $9.7M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $12.15M |
| Total Assets | Q3 2025 · Mar 31, 2024 | $13.81M |
| Shares Diluted | Q3 2025 · Dec 31, 2023 | 22.54M sh |
| Shares Diluted | Q3 2025 · Dec 31, 2023 | 20.71M sh |
| Capex | Q3 2025 · Dec 31, 2023 | $1.22M |
| Operating Cash Flow | Q3 2025 · Dec 31, 2023 | −$10.45M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $3.85M |
| Stockholders Equity | Q3 2025 · Sep 30, 2023 | $7.94M |
| Stockholders Equity | Q3 2025 · Jun 30, 2023 | $11.56M |
| Stockholders Equity | Q3 2025 · Mar 31, 2023 | $5.08M |
| Eps Diluted | Q3 2025 · Dec 31, 2023 | −$0.23 |
| Eps Diluted | Q3 2025 · Dec 31, 2023 | −$0.64 |
| Eps Basic | Q3 2025 · Dec 31, 2023 | −$0.23 |
| Eps Basic | Q3 2025 · Dec 31, 2023 | −$0.64 |
| Sga Expense restated | Q3 2025 · Dec 31, 2023 | $1.43M |
| Sga Expense restated | Q3 2025 · Dec 31, 2023 | $3.45M |
| Rd Expense restated | Q3 2025 · Dec 31, 2023 | $3.84M |
| Rd Expense restated | Q3 2025 · Dec 31, 2023 | $9.77M |
| Net Income | Q3 2025 · Dec 31, 2023 | −$5.27M |
| Net Income | Q3 2025 · Dec 31, 2023 | −$13.19M |
| Net Income | Q3 2025 · Sep 30, 2023 | −$4.18M |
| Net Income | Q3 2025 · Jun 30, 2023 | −$3.74M |
| Operating Income | Q3 2025 · Dec 31, 2023 | −$5.27M |
| Operating Income | Q3 2025 · Dec 31, 2023 | −$13.21M |